Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study (Q43055100)
Jump to navigation
Jump to search
scientific article published in October 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study |
scientific article published in October 2010 |
Statements
1 reference
Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study (English)
1 reference
1 reference
Paul D Miller
1 reference
Jonathan D Adachi
1 reference
Jacques Brown
1 reference
Robert A Adler
1 reference
Christina Bucci-Rechtweg
1 reference
Aimee Readie
1 reference
Peter Mesenbrink
1 reference
Robert S Weinstein
1 reference
1 October 2010
1 reference
1 reference
Identifiers
1 reference